From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care
- PMID: 14530957
- DOI: 10.1007/s00520-003-0539-4
From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care
Abstract
In recent years a paradigm shift towards a patient-focused rather than a disease-focused approach occurred in many health care systems. The pharmacy profession experienced an accordant development. The traditional drug-oriented services expanded towards patient-oriented services. In oncology, pharmacists established central services for compounding of cytotoxic drugs and offered therapeutic drug monitoring for critical substances. Pharmaceutical care concepts are now being introduced to optimize individual drug therapy. Pharmaceutical care aims at improving safety and therapeutic outcomes and consequently, the patient's quality of life. These objectives imply a close relationship to supportive care. To achieve this, a multidisciplinary approach seems to be beneficial.
Similar articles
-
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.J Oncol Pharm Pract. 2021 Jun;27(4):785-801. doi: 10.1177/10781552211017199. Epub 2021 May 22. J Oncol Pharm Pract. 2021. PMID: 34024179
-
Clinical pharmacy services and research for lymphoma patients at a cancer center.J Oncol Pharm Pract. 2013 Mar;19(1):24-30. doi: 10.1177/1078155212449031. Epub 2012 Jun 15. J Oncol Pharm Pract. 2013. PMID: 22706787
-
A shared fight against cancer: the complementary roles of oncology physicians and oncology pharmacists.Expert Rev Anticancer Ther. 2013 Jan;13(1):13-5. doi: 10.1586/era.12.143. Expert Rev Anticancer Ther. 2013. PMID: 23259422
-
Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy.Lancet Oncol. 2009 Oct;10(10):1011-9. doi: 10.1016/S1470-2045(09)70104-4. Lancet Oncol. 2009. PMID: 19796753 Review.
-
New anticancer agents: role of clinical pharmacy services.Anticancer Res. 2014 Apr;34(4):1573-8. Anticancer Res. 2014. PMID: 24692684 Review.
Cited by
-
A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan.BMC Public Health. 2016 Jul 8;16:534. doi: 10.1186/s12889-016-3208-5. BMC Public Health. 2016. PMID: 27392676 Free PMC article.
-
Minimising treatment-associated risks in systemic cancer therapy.Pharm World Sci. 2008 Apr;30(2):161-8. doi: 10.1007/s11096-007-9157-4. Epub 2007 Sep 29. Pharm World Sci. 2008. PMID: 17906939 Free PMC article. Review.
-
Démarche pour la mise à niveau d'un secteur de soins pharmaceutiques : le cas de l'hémato-oncologie pédiatrique.Can J Hosp Pharm. 2010 Mar;63(2):119-29. doi: 10.4212/cjhp.v63i2.897. Can J Hosp Pharm. 2010. PMID: 22478967 Free PMC article. French.
-
Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units.Support Care Cancer. 2010 Jul;18(7):811-6. doi: 10.1007/s00520-009-0713-4. Epub 2009 Aug 7. Support Care Cancer. 2010. PMID: 19662439
-
Evaluation of clinical interventions made by pharmacists in chemotherapy preparation.Radiol Oncol. 2010 Dec;44(4):249-56. doi: 10.2478/v10019-010-0040-x. Epub 2010 Sep 22. Radiol Oncol. 2010. PMID: 22933924 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources